diabetes

Noninvasive imaging could replace finger pricks for measuring blood glucose

Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs

Enzyme behind diet-induced obesity and diabetes can be ‘switched off’ | Switching off an enzyme in mice prevented diet-induced obesity and improved metabolism

Cannabis use associated with quadrupled risk of developing type 2 diabetes

Crispr Offers New Hope for Treating Diabetes

Scientists have identified a protein that acts as a traffic controller for fat inside cells, revealing a mechanism that could help explain how the body regulates energy storage | The discovery provides a new avenue for treating obesity and type 2 diabetes

Stem Cell Treatment May Cure Severe Type 1 Diabetes, Study Finds

People with Severe Type 1 Diabetes are Cured in Small Trial of New Drug

Doctors could hack the nervous system with ultrasound

Why Women With Type 2 Diabetes Are Diagnosed Later Than Men

Diabetes Is Rising in Africa. Could It Lead to New Breakthroughs?

Coffee reduces risk of Type 2 Diabetes; okay to add cream, but not sweetener

Facebook scammers want you to think Elon Musk can cure diabetes

Type 2 diabetes: New plant-based pill shows promise in human trials | The researchers found that in addition to reducing liver fat content, HTD1801 significantly improved blood glucose control.

Type 1 diabetes reversed by new cell transplantation technique

Swiss scientists unveil ‘gene switch’ patch to start cell therapy for diabetes | The ETH Zurich team states that this cell therapy has the potential to offer a more precise and personalized treatment for diabetes.

"Functional cure" for diabetes restores insulin production with stem cells | A patient with type 1 diabetes has been functionally cured of the disease. The treatment involves growing and transplanting new insulin-producing cells from the patient’s own stem cells.

Study links sugar-filled drinks to millions of heart disease and diabetes cases

Type 2 Diabetes and cardiovascular disease attributable to sugar beverages

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes